Physical activity had a remarkably similar effect to the over-expression of CB1 receptors. Mice that were genetically altered ...
ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...
These receptors initiate two arms of the immune ... TLRs can interact with the now-exposed pathogen DNA and RNA. TLRs have complex expression patterns in different cell types.
Hoth Therapeutics (HOTH) announced breakthrough preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted therapy for ...
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
A novel mouse model offers definitive evidence that a single inhibitory receptor family governs the critical natural killer cell functions of licensing and missing-self.